Christopher Michael Chipman - Net Worth and Insider Trading

Christopher Michael Chipman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Michael Chipman owns 1 companies in total, including Virpax Pharmaceuticals Inc (VRPX) .

Click here to see the complete history of Christopher Michael Chipman’s form 4 insider trades.

Insider Ownership Summary of Christopher Michael Chipman

Ticker	Comapny	Transaction Date	Type of Owner
VRPX	Virpax Pharmaceuticals Inc	2021-04-07	Chief Financial Officer

Christopher Michael Chipman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Michael Chipman Ownership Network

Ownership Network List of Christopher Michael Chipman

No Data

Ownership Network Relation of Christopher Michael Chipman

Christopher Michael Chipman Owned Company Details

What does Virpax Pharmaceuticals Inc do?

Who are the key executives at Virpax Pharmaceuticals Inc?

Christopher Michael Chipman is the Chief Financial Officer of Virpax Pharmaceuticals Inc. Other key executives at Virpax Pharmaceuticals Inc include Chief Scientific Officer Sheila Mathias , Chief Financial Officer Vinay Shah , and director & 10 percent owner & Chief Executive Officer Anthony P. Mack .

Virpax Pharmaceuticals Inc (VRPX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Virpax Pharmaceuticals Inc (VRPX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Virpax Pharmaceuticals Inc (VRPX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Virpax Pharmaceuticals Inc (VRPX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Virpax Pharmaceuticals Inc Insider Transactions

No Available Data

Christopher Michael Chipman Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Michael Chipman. You might contact Christopher Michael Chipman via mailing address: C/o Virpax Pharmaceuticals, Inc., 1554 Paoli Pike #279, West Chester Pa 19380.

Discussions on Christopher Michael Chipman

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.